Multicystic dysplastic kidney

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1851Q61.4
Who is this for?
Show terms as
11Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Multicystic dysplastic kidney (MCDK), also known as multicystic renal dysplasia, is a congenital condition in which one or both kidneys fail to develop normally during fetal life, resulting in a non-functioning kidney replaced by multiple cysts of varying sizes separated by dysplastic tissue. It is one of the most common causes of an abdominal mass in newborns. The condition is thought to arise from abnormal interaction between the ureteric bud and the metanephric mesenchyme during embryonic kidney development, often associated with ureteral atresia. MCDK most commonly affects only one kidney (unilateral), with the contralateral kidney typically undergoing compensatory hypertrophy to maintain normal renal function. The affected kidney lacks normal renal architecture and is essentially non-functional. In unilateral cases, most children are asymptomatic and are diagnosed prenatally through routine ultrasound screening, which reveals a kidney replaced by multiple non-communicating cysts. The affected kidney usually involutes (shrinks) over time, and many cases resolve spontaneously during childhood. However, the contralateral kidney may have associated abnormalities such as vesicoureteral reflux or ureteropelvic junction obstruction in a proportion of cases, which requires monitoring. Bilateral MCDK is incompatible with life due to the absence of functional renal tissue, leading to oligohydramnios and pulmonary hypoplasia. Management of unilateral MCDK is generally conservative, involving serial ultrasound monitoring to track involution of the affected kidney and to ensure the health and compensatory growth of the contralateral kidney. Nephrectomy (surgical removal of the affected kidney) was historically performed routinely but is now typically reserved for cases with complications such as persistent enlargement, hypertension, recurrent infections, or concern for malignancy, though the risk of malignant transformation (such as Wilms tumor) is considered extremely low. Long-term follow-up includes monitoring blood pressure and renal function, as some patients may develop hypertension or mild renal impairment over time.

Also known as:

Clinical phenotype terms— hover any for plain English:

Abdominal massHP:0031500UreteroceleHP:0000070Ureteropelvic junction obstructionHP:0000074Ureterovesical junction obstructionHP:0030735
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Multicystic dysplastic kidney.

View clinical trials →

No actively recruiting trials found for Multicystic dysplastic kidney at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Multicystic dysplastic kidney community →

Specialists

11 foundView all specialists →
QM
Quang T Nguyen, M.D.
Specialist
PI on 4 active trials
AM
Ayman Kassem, MD
Specialist
PI on 1 active trial1 Multicystic dysplastic kidney publication
AM
Ahmed Sharawy, MD
Specialist
PI on 1 active trial1 Multicystic dysplastic kidney publication
ME
Mohammed Elghorably
Specialist
PI on 1 active trial40 Multicystic dysplastic kidney publications
LM
Luke Harper, MD
Specialist
PI on 1 active trial1 Multicystic dysplastic kidney publication
VJ
Vijaya Vemulakonda, MD, JD
Aurora, Colorado
Specialist

Rare Disease Specialist

PI on 1 active trial
MP
Mohammed S ElSheemy, A professor
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Multicystic dysplastic kidney.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Multicystic dysplastic kidneyForum →

No community posts yet. Be the first to share your experience with Multicystic dysplastic kidney.

Start the conversation →

Latest news about Multicystic dysplastic kidney

No recent news articles for Multicystic dysplastic kidney.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Multicystic dysplastic kidney

What is Multicystic dysplastic kidney?

Multicystic dysplastic kidney (MCDK), also known as multicystic renal dysplasia, is a congenital condition in which one or both kidneys fail to develop normally during fetal life, resulting in a non-functioning kidney replaced by multiple cysts of varying sizes separated by dysplastic tissue. It is one of the most common causes of an abdominal mass in newborns. The condition is thought to arise from abnormal interaction between the ureteric bud and the metanephric mesenchyme during embryonic kidney development, often associated with ureteral atresia. MCDK most commonly affects only one kidney

How is Multicystic dysplastic kidney inherited?

Multicystic dysplastic kidney follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Multicystic dysplastic kidney typically begin?

Typical onset of Multicystic dysplastic kidney is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Multicystic dysplastic kidney?

11 specialists and care centers treating Multicystic dysplastic kidney are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.